Emerald Health Therapeutics' Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability

Stock Information for Emerald Health Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.